(ATLN:SIX SWISS EXCHANGE AG)
Jean-Paul Clozel M.D.
Founder, Chief Executive Officer, Member of Management Board and Director, Actelion Ltd.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 3 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Jean-Paul Clozel, MD founded Actelion Pharmaceuticals U.S., Inc. in 1997 and has been its Chief Executive Officer since April 2000. Mr. Clozel is the Founder of Actelion Ltd., (Actelion AG ) and has been its Chief Executive Officer since 1999 and serves as its Member of Management Board. He was a Practicing Cardiologist for 11 years, from 1974 to 1985. He served as the Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche for 12 years, ...
Gewerberstrasse 16Phone: 41 61 565 65 65
Allschwil, Basel-Landschaft 4123
Fax: 41 61 565 65 00
Board Members Memberships*
Founder, Chief Executive Officer, Member of Management Board and Director
Founder, Chief Executive Officer, Member of The Board and Member of Executive Committee
Education*There is no Education data available.
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Martine A. Rothblatt Ph.D., MBA, J.D.||Founder, Chairman and Chief Executive Officer|
United Therapeutics Corporation
|Marc M.P. de Garidel||Chairman, Chief Executive Officer and Member of Strategic Committee|
|Frederic Roch Doliveux DVM||Chief Executive Officer and Executive Director|
|Jörg-Thomas Dierks||Chief Executive Officer|
|kr2.1M||Compensation as of Fiscal Year 2013.|